MKI67 and cancer: It reveals that MAE modulates important cancer hallmarks, such as p53 activation, suppression of proliferation factor Ki67, inhibition of invasion and metastasis mediators MMP-9 and STAT-3, and alteration of cell cycle dynamics, in addition to exerting concentration and time-dependent cytotoxic effects.